title: [Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer].
authors.affiliation: Universitäts-Frauenklinik Heidelberg.
authors.forename: H
authors.initials: H
authors.lastname: Schmid
authors.forename: E
authors.initials: E
authors.lastname: Schachner-Wünschmann
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D002064:Buserelin / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D017273:Goserelin; D006801:Humans; D007279:Injections, Subcutaneous; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged
chemical_list: D003692:Delayed-Action Preparations; D017273:Goserelin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D002064:Buserelin
vernacular_title: ZOLADEX als Depot GnRH-Agonist beim prämenopausalen metastasierten Mammakarzinom.